Fixing today, building tomorrow: delivering cancer care now and for the future
- Date
- 21 Oct 2026
- Time
- 8.15am – 5.00pm
- Location
- The King's Fund, London, W1G 0AN
- Price
- From £110 +VAT
Novartis Pharmaceuticals UK Ltd (Novartis) has fully funded this non-promotional initiative, as part of our 2026 corporate partnership with The King’s Fund. Novartis has contributed to topics included, with The King’s Fund owning the final decision and delivery of content. All activities owned and delivered by Novartis are clearly declared separately.
Lord Darzi’s independent investigation into the NHS in England delivered a stark assessment of cancer care. Highlighting the gap between policy and reality, it found that the NHS is failing to meet some of its most important commitments, with core cancer waiting time standards missed for more than a decade and survival rates lagging behind comparable countries.
The government’s 10-year National Cancer Plan for England sets out bold ambitions to improve survival, boost early diagnosis, and deliver more equitable, patient-centred care. With ambitious targets set for 2029 and 2035, the key question remains: can the NHS deliver these commitments while still fixing today’s pressures?
At this pivotal moment, leaders across the health and care system face the challenge of building cancer services that are not only fit for today, but ready to adopt the next wave of innovation. Progress is already visible in areas, but translating national ambition into consistent, real-world improvement for patients will require co-ordinated action across the system.
This conference brings together leaders from cancer alliances, policy, clinical services, commissioning, and the VCSE sector to explore what is working, and what must change, to turn plans into practice.
Across the day sessions will explore:
• Why progress in cancer care can stall in practice, from access to funding and capacity challenges and what it takes to turn policy real-world delivery.
• How systems can redesign services and make difficult prioritisation decisions to deliver high-quality, equitable care within existing constraints.
• What it will take to improve patient experience and outcomes while adopting innovation at pace across the system.
Event partner
Event supporter
Speakers include
-
Johan Kahlström
President & Managing Director UK & Ireland, Novartis Pharmaceuticals UK -
Gemma Peters
Chief Executive, Macmillan Cancer Support -
Dr Richard Roope
Primary Care Cancer Lead, Hampshire and Isle of Wight Cancer Alliance and GP, Wessex Rapid Investigation Service -
Professor Peter Johnson
National Clinical Director for Cancer, NHS England -
Joni Jabbal
Head of National Systems Change, Macmillan Cancer Support -
Siva Anandaciva
Director of Policy, Events, and Partnerships
Get in touch about sponsorship and exhibition
If you would like a conversation about your business goals, and how being involved with future events can help you, you find out more here or email the Partnerships team.
Programme
Cancer care is under growing pressure, with progress uneven across the system. Join us to explore what’s working, what isn’t, and what it takes to turn ambition into real improvements for patients.
Ticket prices
Please note, there is a £20+VAT surcharge to cover the cost of processing invoices. This is in addition to the ticket price and will be added to your invoice. There is one invoice fee per order, not per ticket. There is no charge for paying by debit or credit card.
Free tickets
We offer a limited number of free tickets for people with lived experience to ensure a balance of voices in the room. To apply for a free place, please complete our free ticket request form and a member of the Events team will aim to respond within two working days. We will only consider requests made using this form.
-
Community groups and small charities
-
Charities and public sector
-
Small-medium sized enterprise (SME)
-
Commercial (large private company)
Frequently asked questions
Got a question about our events? Go to our frequently asked questions.
Contact us
-
Booking or programme enquiries
-
Sponsorship and exhibition enquiries
FA-11711770
Date of Preparation June 2026
)